Literature DB >> 18956598

Third Chinese National Consensus Report on the management of Helicobacter pylori infection.

Fu Lian Hu1, Pin Jin Hu, Wen Zhong Liu, Ji De Wang, Nong Hua Lv, Shu Dong Xiao, Wan Dai Zhang, Hong Cheng, Yong Xie.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18956598     DOI： 10.1111/j.1751-2980.2008.00342.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN： 1751-2972            Impact factor:   2.325


× No keyword cloud information.
  12 in total

1.  Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.

Authors:  Li-Hui Wang; Hong Cheng; Fu-Lian Hu; Jiang Li
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

3.  Centralized isolation of Helicobacter pylori from multiple centers and transport condition influences.

Authors:  Ya-Nan Gong; You-Ming Li; Ning-Min Yang; Hong-Zhang Li; Feng Guo; Lang Lin; Qun-Ying Wang; Jia-Kun Zhang; Zi-Zhong Ji; Ji-Bo Mao; Jun-Liang Mao; Zheng-Chao Shi; Wu-Heng Tang; Xin-Jian Zhu; Wei Shao; Xiao-Feng Zhang; Xing-Hua Wang; Yue-Feng Tong; Mi-Zu Jiang; Guang-Lan Chen; Zhi-Yong Wang; Hui-Min Tu; Guo-Fa Jiang; Jian-Sheng Wu; Xu-Peng Chen; Qiu-Long Ding; Hong Ouyang; Feng-Zhe Jin; Yan-Li Xu; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 4.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 5.  Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.

Authors:  Sun-Young Lee
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori.

Authors:  Hong Cheng; Fu-Lian Hu
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 7.  Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China.

Authors:  Hong Lu; Wei Zhang; David Y Graham
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 2.566

8.  Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.

Authors:  Jie Pan; Zhengchao Shi; Dingsai Lin; Ningmin Yang; Fei Meng; Lang Lin; Zhencheng Jin; Qingjie Zhou; Jiansheng Wu; Jianzhong Zhang; Youming Li
Journal:  Front Med       Date:  2020-01-03       Impact factor: 4.592

9.  Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China.

Authors:  Chun-Hua Wang; Sheng-Tao Liao; Jun Yang; Chun-Xia Li; Ying-Ying Yang; Ran Han; Dong-Feng Chen; Chun-Hui Lan
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 10.  Effectiveness of Helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference.

Authors:  Takeshi Seta; Yoshimitsu Takahashi; Yoshinori Noguchi; Satoru Shikata; Tatsuya Sakai; Kyoko Sakai; Yukitaka Yamashita; Takeo Nakayama
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.